Search Results

FILTER BY

1 - 12 of 278 matches

Sort by:
  • NewsConference NewsCX Symposium 2025

    Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

    L.A. McKeown

    April 24, 2025

  • NewsConference NewsVIVA 2024

    Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

    L.A. McKeown

    November 5, 2024

  • PresentationTCT 2024

    Insights and Innovations in Scaffold Technologies for Peripheral Intervention: Bioresorbable and Metal Scaffolds Are The Answer

    Presenter:  

    Sahil Parikh

    October 30, 2024

  • PresentationTCT 2024

    Coronary Bioresorbable Vascular Scaffolds: Any Chance of Resurrection?

    Presenter:  

    Grzegorz Kaluza

    October 30, 2024

  • PresentationTCT 2024

    TCT 363: Five-Year Clinical Outcomes of Patients Treated With the XINSORB Bioresorbable Sirolimus-Eluting Scaffolds

    Presenter:  

    Jiasheng Yin

    October 27, 2024

  • NewsConference NewsESC 2024

    ‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

    Michael O'Riordan

    September 9, 2024

  • NewsDaily News

    FDA Medical Devices Chief Jeff Shuren Announces Retirement

    L.A. McKeown

    July 24, 2024

  • NewsConference NewsACC 2024

    PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

    L.A. McKeown

    April 8, 2024

  • NewsOpinionOff Script

    Evoque and Patisiran: A Tale of Two Regulatory Journeys

    Sanjay Kaul, MD

    March 29, 2024

  • NewsConference NewsISET 2024

    Will IVUS Ever Take Off in Peripheral Vascular Interventions?

    Caitlin E. Cox

    January 31, 2024

  • NewsConference NewsTCT 2023

    LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

    L.A. McKeown

    October 25, 2023

  • PresentationTCT 2023

    TCT 440: Physiological Patterns of Coronary Artery Disease and Percutaneous Coronary Intervention with Bioresorbable Vascular Scaffolds

    Presenter:  

    SIMONE FEZZI

    October 25, 2023